AJAbbas Jamali

Abbas Jamali

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abbas Jamali has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Asghar Abdoli

    Department of Hepatitis and HIV, Pasteur Institute of Iran, Tehran, Iran

    3 shared publications
  • Masoumeh Tavassoti Kheiri

    Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, No. 358, 12th Farwardin Ave, Jomhhoori St, Tehran, Iran

    2 shared publications
  • Mohammad Hasan Samiee Aref

    Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, No. 358, 12th Farwardin Ave, Jomhhoori St, Tehran, Iran

    2 shared publications
  • Narges Rasouli

    Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, No. 358, 12th Farwardin Ave, Jomhhoori St, Tehran, Iran

    2 shared publications
  • Nasim Sadat Seyed Tabib

    Department of Chronic Diseases, Metabolism and Ageing, TARGID, KU Leuven, Leuven, Belgium

    2 shared publications
  • Peyvand Biglari

    Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, No. 358, 12th Farwardin Ave, Jomhhoori St, Tehran, Iran

    2 shared publications

Latest Publications

  • Molecular epidemiology of the hemagglutinin gene of prevalent influenza virus A/H1N1/pdm09 among patient in Iran

    by Atefeh Mohebbi, Fatemeh Fotouhi, Abbas Jamali, Ramin Yaghobi, Behrokh Farahmand, Reza Mohebbi


  • Open Access

    Oil-in-water emulsion formulated with eucalyptus leaves extract inhibit influenza virus binding and replication in vitro

    by Maryam Sadat Sadatrasul, Neda Fiezi, Nasir Ghasemian, Mohammad Shenagari, Saber Esmaeili, Ehsan Ollah Jazaeri, Asghar Abdoli, Abbas Jamali

    Throughout human history, the human-beings have been used different types of plants as antimicrobial agents in fight against infectious diseases. Influenza virus is one of the most common causes of respiratory infection and transmitted through direct contact with flu infected individuals and contaminated substances or droplets. In the current study, both oil-in-water and water-in-oil emulsions with hydroalcoholic extract of eucalyptus leaves (OLHE) were developed and their antiviral efficiency was evaluated. To doing so, Madin-Darbey Canine Kidney (MDCK) cells were treated with effective minimal cytotoxic concentration of the formulated emulsions. The treated cells were then infected with 50% cell culture infectious dose (100 CCID50) of the A/H1N1 virus (the swine flu). The viral titers were measured by hemagglutination (HA) and cell culture infectious dose 50% (CCID50) assays. Also, to check the virus binding inhibition via the formulated extract, the viruses were incubated with the formulated extracts. Our study showed that the oil-in-water emulsions formulated with 2% eucalyptus leaves extract inhibited virus replication completely when the cells were infected by 100 CCID50 and decreased HA titer up to four fold. Therefore, this formulation, may hold promising application to prevent influenza virus transmission through direct contact among children and passengers.


  • A novel chimeric influenza virosome containing Vesicular stomatitis G protein as a more efficient gene delivery system

    by Yahya Mohammadzadeh, Narges Rasouli, Mohammad Hasan Samiee Aref, Nasim Sadat Seyed Tabib, Asghar Abdoli, Peyvand Biglari, Maryam Saleh, Mansoureh Tabatabaeian, Masoumeh Tavassoti Kheiri, Abbas Jamali

    Objectives To enhance the efficiency of influenza virosome-mediated gene delivery by engineering this virosome. Results A novel chimeric influenza virosome was constructed containing the glycoprotein of Vesicular stomatitis virus (VSV-G), along with its own hemagglutinin protein. To optimize the transfection efficiency of both chimeric and influenza cationic virosomes, HEK cells were transfected with plasmid DNA and virosomes and the transfection efficiency was assessed by FACS analysis. The chimeric virosome was significantly more efficient in mediating transfection for all amounts of DNA and virosomes compared to the influenza virosome. Conclusions Chimeric influenza virosome, including VSV-G, is superior to the conventional influenza virosome for gene delivery.


  • Introduction of cationic virosome derived from vesicular stomatitis virus as a novel gene delivery system for sf9 cells

    by Yahya Mohammadzadeh, Shima Gholami, Narges Rasouli, Sahar Sarrafzadeh, Nasim Sadat Seyed Tabib, Mohammad Hasan Samiee Aref, Asghar Abdoli, Peyvand Biglari, Fatemeh Fotouhi, Behrokh Farahmand, et al.

    Insect-derived cell lines are used extensively to produce recombinant proteins because they are capable of performing a range of post-translational modifications. Due to their significance in biotechnological applications, various methods have been developed to transfect them. In this study, we introduce a virosome constructed from vesicular stomatitis virus (VSV) as a new delivery system for sf9 cells. We labeled these VSV virosomes by fluorescent probe Rhodamine B chloride (R18). By fluorescence microscope observation and conducting a fusion assay, we confirmed the uptake of VSV virosomes via endocytosis by sf9 cells and their fusion with the endosomal membrane. Moreover, we incubated cationic VSV virosomes with a GFP-expressing bacmid and transfected sf9 cells, after 24 h some cells expressed GFP indicating the ability of VSV virosomes to deliver heterologous DNA to these cells. This is the first report of a virosome-based delivery system introduced for an insect cell line.


  • Withdrawal from Morphine Reduces Cell-Mediated Immunity against Herpes Simplex Virus Generated by Natural Immunization

    by Abbas Jamali, Hoorieh Soleimanjahi, Mostafa Moin, Mehdi Mahdavi, Hamidreza Hashemi, Farzaneh Sabahi, Zuhair M. Hassan, Taravat Bamdad

    In a previous study, the authors have shown that herpes simplex virus type 1 (HSV-1) glycoprotein B DNA vaccine but not live vaccine (non-virulent KOS strain) failed to induce protective immunity against acute HSV-1 challenge in morphine-dependent mice. The present study reports the effect of morphine withdrawal on protective immunity induced by live HSV-1 immunization. BALB/c mice were vaccinated with KOS strain as a live vaccine. Three weeks later, they were exposed to morphine for 14 days. On day 14, withdrawal was induced by administration of normal saline instead of morphine. One day later, immune responses against HSV-1 were assessed by measuring cytotoxicity, lymphocyte proliferation and interferon-γ production. Protection against HSV-1 was assessed by measuring the mortality rate after acute HSV-1 challenge. The results showed that withdrawal from morphine reduces protective immunity against acute HSV-1 challenge. These findings raise the possibility that withdrawal from morphine may increase the susceptibility of drug addicts to infectious diseases.